Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 02/18/2025 at 15:00, 1 year 4 months ago

Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300
Jaguar Health and Napo Pharmaceuticals extend collaboration with Streeterville related to development of NP-300 drug product candidate for cholera patients, aiming for Tropical Disease Priority Review Voucher from FDA

Napo Pharmaceuticals Jaguar Health Cholera NP-300 Tropical Disease Priority Review Voucher
BRIEF

published on 02/13/2025 at 15:10, 1 year 4 months ago

Jaguar Health to Present at Emerging Growth Conference

Forward-looking Statements Jaguar Health Lisa Conte Emerging Growth Conference Gastrointestinal Medicines
BRIEF

published on 02/13/2025 at 15:10, 1 year 4 months ago

Jaguar Health participera à la conférence Emerging Growth

Lisa Conte Conférence Sur La Croissance Émergente Santé Jaguar Énoncés Prospectifs Médicaments Gastro-intestinaux
PRESS RELEASE

published on 02/13/2025 at 15:05, 1 year 4 months ago

Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
Jaguar Health, Inc. founder Lisa Conte to present virtually at Emerging Growth Conference on Feb 18, 2025. Company focuses on sustainable pharmaceuticals derived from rainforest plants for gastrointestinal distress

Pharmaceuticals Gastrointestinal Distress Jaguar Health Lisa Conte Emerging Growth Conference
BRIEF

published on 02/06/2025 at 16:05, 1 year 4 months ago

Magdalena Biosciences to Present at BIO CEO & Investor Conference

Mental Health Magdalena Biosciences IND Application Botanical Drugs MB2500
BRIEF

published on 02/06/2025 at 16:05, 1 year 4 months ago

Magdalena Biosciences fera une présentation à la conférence des PDG et investisseurs de BIO

Santé Mentale Demande D'IND Biosciences De Magdalena Médicaments À Base De Plantes MB2500
PRESS RELEASE

published on 02/06/2025 at 16:00, 1 year 4 months ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena to submit IND application for psychoactive drug candidate for mental health indications. MB2500 aims to treat cognitive deficit in schizophrenia and ADHD. Magdalena focuses on safe, plant-based drugs under FDA Botanical Guidance

Mental Health IND Application Magdalena Psychoactive Drug Cognitive Deficit
BRIEF

published on 02/03/2025 at 15:35, 1 year 4 months ago

Jaguar Health Commences Pivotal Crofelemer Trial for SBS-IF and MVID

Crofelemer Clinical Trials Orphan Drugs MVID SBS-IF
BRIEF

published on 02/03/2025 at 15:35, 1 year 4 months ago

Jaguar Health lance un essai pivot sur Crofelemer pour le SBS-IF et le MVID

Crofelemer Essais Cliniques MVID Médicaments Orphelins SBS-SI
PRESS RELEASE

published on 02/03/2025 at 15:30, 1 year 4 months ago

Jaguar Health Announces First Patient Dosed in Short Bowel Syndrome with Intestinal Failure in Investigator-Initiated Trial of Crofelemer; Proof-of-Concept Data Potentially Available H1 2025
Sheikh Khalifa Medical City hosts trial for Jaguar's crofelemer, plant-based drug granted Orphan Drug Designation. Study could lead to early patient access in Europe for rare diseases

Crofelemer Orphan Drug Designation SBS-IF Sheikh Khalifa Medical City Jaguar

Published on 06/27/2026 at 01:40, 3 hours 6 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 4 hours 46 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 5 hours 46 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 5 hours 56 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 6 hours 31 minutes ago

Revive Therapeutics Announces Proposed Private Placement

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 4 hours 41 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 4 hours 42 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 5 hours 10 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 5 hours 10 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 5 hours 18 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 11 hours 1 minute ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 11 hours 1 minute ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 11 hours 1 minute ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 14 hours 2 minutes ago

Safran information
Published on 06/26/2026 at 14:44, 14 hours 2 minutes ago

Information Safran

View all LES ECHOS COMFI WIRE

News